Audience Led Discussion: Pushing Pipeline into the Clinic
Time: 2:00 pm
day: Conference Day Two - Track B - PM
Details:
- Establishing a comprehensive understanding of the regulatory landscape for allogeneic off-the-shelf gamma delta T cell therapies
- Covering key aspects such as regulatory considerations for the future, prepping for a BLA, IND filing procedures and overall navigating the journey from IND filing to getting into the clinic
- Open mic for direct questions with industry KOLs
